Antioxidants are indispensable in protecting the skin from oxidative stress caused by environmental factors such as ultraviolet (UV) radiation, pollution, and lifestyle-related influences. This review examines the essential role of antioxidants in modern cosmetology, highlighting their dual functionality as protective agents and active components in skincare formulations. Oxidative stress, primarily driven by an imbalance between reactive oxygen species (ROS) production and the skin’s defense mechanisms, accelerates aging processes, damages cellular structures, and compromises skin integrity. Antioxidants, whether natural or synthetic, act by neutralizing ROS, reducing inflammation, and promoting cellular repair, effectively mitigating these harmful effects. This comprehensive analysis synthesizes findings from 280 studies accessed via key databases, including PubMed, Scopus, and ScienceDirect. It investigates the biochemical mechanisms of antioxidant activity, emphasizing compounds such as vitamins (C, E, A), carotenoids, polyphenols, peptides, and minerals, alongside bioactive extracts derived from algae, fungi, lichens, and plants. Carotenoids, including ꞵ-carotene, lutein, lycopene, and astaxanthin, demonstrate potent antioxidant activity, making them crucial for photoprotection and anti-aging. Phenolic compounds, such as ferulic acid, resveratrol, hesperidin, and xanthohumol, play a significant role in neutralizing oxidative stress and improving skin health. This review also highlights bioactives from algae, fungi, and lichens. Algae, particularly microalgae like Haematococcus pluvialis, known for astaxanthin production, are highlighted for their extraordinary photoprotective and anti-aging properties. Brown algae (Fucus vesiculosus) and red algae (Porphyra) provide polysaccharides and bioactive molecules that enhance hydration and barrier function. Fungi contribute a wealth of antioxidant and anti-inflammatory compounds, including polysaccharides, ꞵ-glucans, and enzymes, which support cellular repair and protect against oxidative damage. Lichens, through unique phenolic metabolites, offer potent free-radical-scavenging properties and serve as effective ingredients in formulations targeting environmental stress. Plant-derived antioxidants offer a diverse range of benefits. Plant-derived antioxidants, such as flavonoids, phenolic acids, and carotenoids, further amplify skin resilience, hydration, and repair mechanisms, aligning with the growing demand for nature-inspired solutions in cosmetics. The integration of these diverse natural sources into cosmetic formulations reflects the industry’s commitment to sustainability, innovation, and efficacy. By harnessing the synergistic potential of bioactives from algae, fungi, lichens, and plants, modern cosmetology is advancing toward multifunctional, health-conscious, and eco-friendly products. Future research directions include optimizing delivery systems for these bioactives, enhancing their stability and bioavailability, and expanding their applications to meet evolving dermatological challenges.

The well-known medicinal plant Plantago lanceolata L. (ribwort plantain) was effectively propagated by direct organogenesis from segments of leaves and roots using MS medium supplemented with IAA (11.42 μM), kinetin (9.29 μM) for multiplication and IAA (5.71 μM) for rooting. The plantlets were successfully hardened (80 %) and transferred to field cultivation (100 %). Two lines of callus tissue, derived from leaves and roots, were obtained on MS medium without NH₄NO₃ and supplemented with 2,4-D (4.52 μM) and kinetin ( 0.46 μM). From plant materials - leaf rosettes from in vitro, leaves from plants in field cultivation obtained by micropropagation, root-derived callus and leaf-derived callus - sixteen phenylethanoid glucosides representing nine different structures were isolated and identified by spectral methods (1D and 2D NMR) as known for the species: lavandulifolioside (1), plantamajoside (2,) acteoside (3); new for the species: leucosceptoside A (4), martynoside (5), desrhamnosylisoacteoside (6), plantainoside D (7), desrhamnosylacteoside (8) and - 2-(4-hydroxyphenyl)ethyl β-D-glucopyranosyl-(1→3)-4-O-trans- and cis-p-coumaroyl-β-D-glucopyranoside (9) - the latter also being found for the first time in nature and named lancetoside. Only plantamajoside (2) and acteoside (3) were common to all plant materials, the former was the main constituent of calli (1.19 - 2.84 % of dry weight), while the latter was the main constituent of the leaves (1.78 - 10.43 % of dry weight). Flavonoids were present only in plants of field cultivation.

Three species from the Eryngium L. genus—E. campestre, E. maritimum, and E. planum, plants with a rich chemical composition, were selected for phytochemical and biological studies. The applied biotechnological methods allowed to obtain the biomass of these rare or protected species in the form of multiplied shoots (stationary system) and roots cultured in a liquid medium (agitated system). In the extracts from the raw material obtained under in vitro conditions, the content of selected phenolic acids and flavonoids (HPLC-DAD method) as well as the total of polyphenols (Folin–Ciocalteu assay) were quantified. The highest amount of all phenolic compounds was found in extracts from E. planum roots (950.90 ± 33.52 mg/100 g d.w.), and the lowest from E. campestre roots (285.00 ± 10.07 mg/100 g d.w.). The quantitatively dominant compound proved to be rosmarinic acid. The highest amounts were confirmed for E. planum root extract (694.58 mg/100 g d.w.), followed by E. planum (388.95 mg/100 g d.w.) and E. campestre (325.85 mg/100 g d.w.) shoot extracts. The total content of polyphenols was always increased in the biomass from in vitro cultures in comparison to the analogous organs of intact plants of each species. The obtained extracts were assessed for antiprotozoal activity against Acanthamoeba sp. The strength of biological activity of the extracts correlated with the content of phenolic compounds. To our knowledge, this is the first report on the amoebicidal activity of E. campestre, E. maritimum, and E. planum extracts from biomass produced by biotechnological methods.

Glioblastoma (GBM) is the most common malignant neoplasm in adults among all CNS gliomas, with the 5-year survival rate being as low as 5%. Among nanocarriers, liposomal nanoformulations are considered as a promising tool for precise drug delivery. The herein presented study demonstrates the possibility of encapsulating four selected natural compounds (curcumin, bisdemethoxycurcumin, acteoside, and orientin) and their mixtures in cationic liposomal nanoformulation composed of two lipid types (DOTAP:POPC). In order to determine the physicochemical properties of the new drug carriers, specific measurements, including particle size, Zeta Potential, and PDI index, were applied. In addition, NMR and EPR studies were carried out for a more in-depth characterization of nanoparticles. Within biological research, the prepared formulations were evaluated on T98G and U-138 MG glioblastoma cell lines in vitro, as well as on a non-cancerous human lung fibroblast cell line (MRC-5) using the MTT test to determine their potential as anticancer agents. The highest activity was exhibited by liposome-entrapped acteoside towards the T98G cell line with IC₅₀ equal 2.9 ± 0.9 µM after 24 hours of incubation. Noteworthy, curcumin and orientin mixture in liposomal formulation exhibited a synergistic effect against GBM. Moreover, the impact on the expression of apoptosis-associated proteins (p53 and Caspase-3) of acteoside as well as curcumin and orientin mixture, as the most potent agents, was assessed, showing nearly 40% increase as compared to control U-138 MG and T98G cells. It should be emphasized that a new and alternative method of extrusion of the studied liposomes was developed.

The aim of the study is to investigate whether the bioactive compounds isolated from P. lanceolata inflorescences, namely, phenylethanoid glucosides, acteoside, plantamajoside, and a flavonoid, isorhamnetin-3-O-rutinoside-4′-O-glucoside, possessed cytotoxic activity against the selected cancer cell lines. The potential antitumor effects of two phenylethanoid glycosides and one flavonoid were evaluated via MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay on seven human carcinoma cell lines (MCF-7, MDA-MB-231, Caco-2, HepG2, OVCAR-3, U138-MG, U251-MG) and one nontumorigenic mammary epithelial cell line (MCF-12A). For the first time, acteoside was studied in ovarian cancer cell line OVCAR-3, and plantamajoside in all cell lines except breast adenocarcinoma MDA-MB-281 and hepatocarcinoma HepG2. The phenylethanoid glycosides showed stronger cytotoxic activity than that of the glycoside flavonoid. Acteoside and plantamajoside, at concentrations of 200 and 300 μM, respectively, had a highly toxic effect on the selected two cancer cell lines of breast adenocarcinoma MDA-MB-231 and MCF-7, ovarian cancer cell line OVCAR-3, glioblastoma cell line U138-MG, and hepatocarcinoma cell line HepG2. Both glycosides were significantly less cytotoxic towards nontumorigenic cell line MCF-12A; the effect appeared at a concentration of 400 μM. For the first time, the activity of acteoside and plantamajoside was compared in one parallel investigation. The results are discussed against a broad background of existing knowledge on biological effects, their mechanisms, and structure–activity relationships. Phenylethanoids may be potential compounds with cytotoxic activity against the selected cancer types.